Abeona Therapeutics (ABEO) has granted equity awards to new non-executive employees who joined the Company. The equity awards were approved in accordance with Nasdaq Listing Rule 5635(c)(4). On November 30, 2025, the Compensation Committee of Abeona’s Board of Directors granted restricted stock equity awards as a material inducement to employment to two individuals hired by Abeona, which equity awards relate to, in the aggregate, up to 45,685 restricted shares of Abeona common stock. One-third of the shares subject to such restricted stock awards will vest yearly on each anniversary of the Grant Date, such that the shares subject to such restricted stock awards granted to each employee will be fully vested on the third anniversary of the Grant Date, in each case, subject to each employee’s continued employment with Abeona on the applicable vesting dates.
Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ABEO:
- Optimistic Buy Rating for Abeona Therapeutics Amid Promising ZEVASKYN Outlook and Favorable Market Conditions
- Abeona Therapeutics: Q3 2025 Financial Insights
- Abeona Therapeutics Earnings Call: Positive Outlook Amid Challenges
- Abeona Therapeutics: Resilient Path to Profitability with Strong Market Demand and Strategic Optimizations
- Abeona Therapeutics price target lowered to $19 from $20 at Stifel
